Facet browsing currently unavailable
Page 4 of 880 results
Sort by: relevance publication year
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines JOURNAL ARTICLE published 22 February 2024 in npj Vaccines Research funded by Knut och Alice Wallenbergs Stiftelse (KAW 2021.0010_VC-2020-0040) | Vetenskapsrådet (2021-05450,2021-03118) |
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore JOURNAL ARTICLE published 25 October 2021 in npj Vaccines |
Th17-related mammary immunity, but not a high systemic Th1 immune response is associated with protection against E. coli mastitis JOURNAL ARTICLE published 24 November 2020 in npj Vaccines |
The dengue-specific immune response and antibody identification with machine learning JOURNAL ARTICLE published 20 January 2024 in npj Vaccines Research funded by Wellcome Trust (215840/Z/19/Z,215840/Z/19/Z,215840/Z/19/Z,215840/Z/19/Z) |
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys JOURNAL ARTICLE published 10 November 2023 in npj Vaccines |
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort JOURNAL ARTICLE published 24 April 2023 in npj Vaccines |
Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination JOURNAL ARTICLE published 8 February 2022 in npj Vaccines |
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development JOURNAL ARTICLE published 17 March 2022 in npj Vaccines |
Promoting versatile vaccine development for emerging pandemics JOURNAL ARTICLE published 11 February 2021 in npj Vaccines |
Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles JOURNAL ARTICLE published 2 June 2023 in npj Vaccines Research funded by Istituto Superiore di Sanità (BB80,BB80,BB80,BB80,BB80,BB80,BB80,BB80,BB80,BB80,BB80,BB80,BB80) |
Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection JOURNAL ARTICLE published 15 May 2018 in npj Vaccines |
Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents JOURNAL ARTICLE published 24 July 2023 in npj Vaccines |
Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2 JOURNAL ARTICLE published 20 January 2024 in npj Vaccines Research funded by EC | Horizon 2020 Framework Programme (101003653) |
Absolute quantitation of binding antibodies from clinical samples JOURNAL ARTICLE published 6 January 2024 in npj Vaccines |
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice JOURNAL ARTICLE published 15 February 2024 in npj Vaccines Research funded by U.S. Department of Defense (W81XWH-19-2-0020,W81XWH-18-2-0040,W81XWH-19-2-0020,W81XWH-19-2-0020) |
Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design JOURNAL ARTICLE published 8 January 2021 in npj Vaccines |
Effects of persistent modulation of intestinal microbiota on SIV/HIV vaccination in rhesus macaques JOURNAL ARTICLE published 11 March 2021 in npj Vaccines Research funded by U.S. Department of Health & Human Services | NIH | NIH Office of the Director (K01OD024876) | U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI120712) |
Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection JOURNAL ARTICLE published 20 February 2024 in npj Vaccines |
Author Correction: Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores JOURNAL ARTICLE published 20 August 2021 in npj Vaccines |
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis JOURNAL ARTICLE published 7 November 2022 in npj Vaccines |